Who is the CEO of Vieworks?

According to the DART company overview, Vieworks' representative director is 김후식 (name as registered in Korean). The company was founded on 1999-09-18.

Where is Vieworks listed?

Vieworks trades on the Korea Exchange KOSDAQ market under the ticker 100120. Its fiscal year ends in December.

Does Vieworks pay a dividend?

Yes. For fiscal 2025, Vieworks paid a cash dividend of ₩690 per common share, a 3.5% yield as stated in its annual report, with a payout ratio of 28.2%. The prior year's dividend was ₩600.

Does Vieworks have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Profit +50% (latest quarterly operating profit up more than 50% year on year); Dividend grower (dividend per share raised three years in a row). These are factual flags, not investment advice.

Which companies are in the same industry as Vieworks?

Under the Korean Standard Industrial Classification recorded on DART, Vieworks is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.

Vieworks KRX:100120KOSDAQ

뷰웍스 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked8since Sep 11

In Q2 2026, Vieworks reported revenue of ₩63.9bn, up 1.9% year on year, and operating profit of ₩10.7bn. Vieworks (뷰웍스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

Filing signals Profit +50% Dividend grower Screener

Vieworks quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩63.9bn	+1.9%	₩10.7bn margin 16.7%	₩16.2bn
Q1 2026	₩58.2bn	+6.9%	₩8.8bn margin 15.2%	₩9.3bn
Q4 2025 derived	₩68.6bn	+14.8%	₩8.5bn margin 12.4%	₩10.5bn
Q3 2025	₩53.7bn	+10.9%	₩4.3bn margin 8.0%	₩6.4bn
Q2 2025	₩62.7bn	+15.6%	₩6.5bn margin 10.4%	₩2.0bn
Q1 2025	₩54.4bn	-10.2%	₩2.1bn margin 3.8%	₩2.1bn
Q4 2024 derived	₩59.7bn	-4.4%	₩6.9bn margin 11.6%	₩9.2bn
Q3 2024	₩48.4bn	-6.3%	₩4.5bn margin 9.4%	₩1.2bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Vieworks top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Vieworks news Korean headlines

Oct 717:43

뷰웍스, 검사 이미지 초당 100Gbps 전송…카메라·광케이블 묶어 공급
한국경제
Oct 714:59

Major뷰웍스, 100Gbps 광전송 COF 통합 솔루션 세계 최초 공개…VISION 2026 출격
헬로티New technology
Oct 710:40

뷰웍스, 100Gbps 광전송 장치 공개
헤럴드경제
Oct 709:52

뷰웍스, 초당 100Gbps '광전송' 승부수
보건신문
Oct 708:54
뷰웍스, 초당 100Gbps 광전송 'COF 통합 솔루션' 첫선
뉴스1
1 more on this story · 1 outlets
- 뷰웍스, 초고속 광전송 'COF 통합 솔루션' 첫 공개메디파나뉴스 · Oct 7 08:59
Oct 610:24

뷰웍스, 반도체 검사 수요 확대…영업익 2배 전망
메디파나뉴스
Sep 1110:28

K-의료기기 해외 진출 확대…리센스메디컬·뷰웍스 등 함박웃음
핀포인트뉴스Overseas expansion

Articles per day 2 weeks

Company profile

CEO: 김후식
Industry: Medical devices
Founded: 1999-09-18
Fiscal year-end: December
Head office: 경기도 안양시
Website: vieworks.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Vieworks dividends annual report

Korea dividend rankings

Year	Per share	Yield	Payout
FY2025	₩690	3.5%	28.2%
FY2024	₩600	2.8%	25.9%
FY2023	₩350	1.3%	21.8%

Raised 3 years in a row

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Seers	₩12.9bn	76
Sky Labs	–	70
Medyssey	–	47
InBody	₩17.7bn	30
Finemedix	₩790m	27
Cosmo Robotics	−₩3.3bn	23
Dynamic solution	−₩950m	20
Hironic	₩1.1bn	19

Compare Vieworks side by side with these companies

Vieworks DART filings

Sep 913:15

Other 신탁계약해지결과보고서
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Vieworks FAQ

Who is the CEO of Vieworks?: According to the DART company overview, Vieworks' representative director is 김후식 (name as registered in Korean). The company was founded on 1999-09-18.
Where is Vieworks listed?: Vieworks trades on the Korea Exchange KOSDAQ market under the ticker 100120. Its fiscal year ends in December.
What were Vieworks' latest quarterly results?: In Q2 2026, Vieworks reported revenue of ₩63.9bn, up 1.9% year on year, and operating profit of ₩10.7bn. Figures come from reports filed on DART.
Does Vieworks pay a dividend?: Yes. For fiscal 2025, Vieworks paid a cash dividend of ₩690 per common share, a 3.5% yield as stated in its annual report, with a payout ratio of 28.2%. The prior year's dividend was ₩600.
Does Vieworks have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Profit +50% (latest quarterly operating profit up more than 50% year on year); Dividend grower (dividend per share raised three years in a row). These are factual flags, not investment advice.
Which companies are in the same industry as Vieworks?: Under the Korean Standard Industrial Classification recorded on DART, Vieworks is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.